glp-1 drugs in development Receptor Agonist Market Size & Analysis, 2026-2033 GLP-1 medications get at the
Description
Further clarification on the hepatic benefits of GLP-1RA is urgently needed, as these insights could contribute to explaining the pharmacological actions in MASLD and the formulation of clinical strategies
However, the lack of available evidence has limited researchers from making definitive conclusions on this potential association
Yet, bridging the gap from lab to market was not straightforward
INTERHEART Study Investigators
